Earnings History Data for Contineum Therapeutics, Inc. (CTNM) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Contineum Therapeutics, Inc.
Contineum Therapeutics Inc. is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies which target biological pathways associated with specific clinical impairments for the treatment of neuroscience, inflammation and immunology indications with high unmet need. The company's product pipeline includes PIPE-791 and PIPE-307. Contineum Therapeutics Inc. is based in SAN DIEGO.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 06-11-2024 | PM | CTNM | Contineum Therapeutics, Inc. | 426.00 | -0.40 | -0.41 | 0.00 | Contineum Therapeutics GAAP EPS of -$0.40 [11/7/2024 9:56 AM] |
18.46 | 1.22 (7.08%) |
17.24 | 0.0 (0.00%) |
13.27 - 22.00 | 115,120 | 80,000 | 1,982 | ||
| 13-08-2024 | AH | CTNM | Contineum Therapeutics, Inc. | 420.00 | -0.39 | -0.37 | 0.00 | Contineum Therapeutics GAAP EPS of -$0.39 [8/14/2024 1:50 PM] |
17.42 | 1.15 (7.07%) |
0.0 | 0.0 (0.00%) |
13.27 - 22.00 | 26,269 | 40,000 | 0 | ||
| 16-05-2024 | AH | CTNM | Contineum Therapeutics, Inc. | 282.00 | -3.55 | -0.53 | 0.00 | Contineum Therapeutics GAAP EPS of -$3.55 [5/16/2024 4:46 PM] |
15.45 | 0.49 (3.28%) |
0.0 | 0.0 (0.00%) |
13.27 - 16.09 | 58,693 | 0 | 0 | ||